+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
From
From
From
Influenza Medication Market Report and Forecast 2023-2031 - Product Thumbnail Image

Influenza Medication Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 160 Pages
  • Global
From
From
From
Alzheimer's Drugs Market Report 2025 - Product Thumbnail Image

Alzheimer's Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024 - Product Thumbnail Image

Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024

  • Clinical Trials
  • February 2018
  • 225 Pages
  • Global
From
From
Unresectable Hepatocellular Carcinoma Market Report 2025 - Product Thumbnail Image

Unresectable Hepatocellular Carcinoma Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Biologics Market Report 2025-2035 - Product Thumbnail Image

Biologics Market Report 2025-2035

  • Report
  • March 2025
  • 367 Pages
  • Global
From
From
From
Microbiome Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Microbiome Collaboration and Licensing Deals 2016-2025

  • Report
  • November 2025
  • 200 Pages
  • Global
From
Loading Indicator